SL
SLN

Siren LLC’s Silence Therapeutics SLN Stock Holding History

Siren LLC’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.3M Hold
2,911,438
– – 0.43% 51
2025
Q4 		$17.7M Hold
2,911,438
– – 0.53% 40
2025
Q3 		$15.1M Hold
2,911,438
– – 0.59% 39
2025
Q2 		$16.9M Buy
2,911,438
+121,605
+4% +$521K 0.87% 32
2025
Q1 		$7.87M Sell
2,789,833
-41,937
-1% -$205K 0.44% 44
2024
Q4 		$19.5M Hold
2,831,770
– – 0.86% 33
2024
Q3 		$51.5M Buy
+2,831,770
New +$52.7M 2.57% 13

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Siren LLC's SLN Position: Q1 2026 in Review

Siren LLC held its Silence Therapeutics (SLN) position steady in Q1 2026 at 2,911,438 shares worth $15.3M. The position accounts for 0.43% of the portfolio, ranked #51.

Siren LLC first reported a position in SLN in Q3 2024 and has held it in 7 quarters since. The position peaked at $51.5M in Q3 2024. 56 funds tracked by Wall St. Rank hold SLN as of Q1 2026.

  • Siren LLC held 2,911,438 shares of Silence Therapeutics worth $15.3M as of Q1 2026.
  • Siren LLC left its Silence Therapeutics share count unchanged in Q1 2026.
  • Silence Therapeutics made up 0.43% of Siren LLC's portfolio in Q1 2026, its #51 holding.
  • Siren LLC first reported a position in Silence Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Siren LLC's Silence Therapeutics position peaked at $51.5M in Q3 2024.
  • 56 funds tracked by Wall St. Rank held Silence Therapeutics as of Q1 2026.

Based on Siren LLC's 13F filing for Q1 2026, filed 14 May 2026.